Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

NovaBay Pharmaceuticals (NBY) Shares Issued (2016 - 2025)

Historic Shares Issued for NovaBay Pharmaceuticals (NBY) over the last 15 years, with Q3 2025 value amounting to $3.8 million.

  • NovaBay Pharmaceuticals' Shares Issued rose 4384.5% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year increase of 2820.51%. This contributed to the annual value of $2.9 million for FY2024, which is 40584.07% up from last year.
  • According to the latest figures from Q3 2025, NovaBay Pharmaceuticals' Shares Issued is $3.8 million, which was up 4384.5% from $614000.0 recorded in Q1 2025.
  • In the past 5 years, NovaBay Pharmaceuticals' Shares Issued registered a high of $3.8 million during Q3 2025, and its lowest value of -$218000.0 during Q4 2021.
  • In the last 4 years, NovaBay Pharmaceuticals' Shares Issued had a median value of $614000.0 in 2025 and averaged $1.3 million.
  • The largest annual percentage gain for NovaBay Pharmaceuticals' Shares Issued in the last 5 years was 36207303.82% (2021), contrasted with its biggest fall of 446000.0% (2021).
  • NovaBay Pharmaceuticals' Shares Issued (Quarter) stood at -$218000.0 in 2021, then skyrocketed by 375.23% to $600000.0 in 2023, then soared by 338.67% to $2.6 million in 2024, then soared by 43.84% to $3.8 million in 2025.
  • Its Shares Issued was $3.8 million in Q3 2025, compared to $614000.0 in Q1 2025 and $2.6 million in Q3 2024.